News & Insights

Tech, AI, science & Apple news curated by Jerry Cards. Unlocking US digital content worldwide since 2009.

Jun 16, 2026, 5:14 AM ETScience

Scientists Just Made the First Global Map of Earth's Underground Fungal Networks - and They Stretch Almost a Billion Times the Distance to the Sun

Microscope image of arbuscular mycorrhizal fungi - paired arbuscules inside flax root cortical cells - illustrating the underground fungal networks mapped globally for the first time in Science (June 2026)

For the first time, scientists have mapped the planet-spanning web of arbuscular mycorrhizal (AM) fungi beneath our feet - and the scale is staggering. Published in Science on June 11, 2026 by the Society for the Protection of Underground Networks (SPUN), the first global map estimates these living fungal threads total roughly 110 quadrillion kilometers (about 68 quadrillion miles) - almost a billion times the distance from Earth to the Sun - with a combined mass near 300 megatons of carbon, four to six times the weight of all living humans. The networks trade nutrients and water with about 70% of plant species, can pack up to 10 meters of thread into a single teaspoon of soil, and help draw an estimated 4 billion tons of CO2-equivalent into the ground each year. Built from more than 16,000 soil cores and robotic imaging of over 300,000 living hyphae, the map reveals a hidden planetary circulatory system - and, for the first time, exactly where to protect it.

Read more →
Jun 16, 2026, 12:14 AM ETHealth

Harvard Tracked 147,000 People for 30 Years - and Found the Strength-Training Sweet Spot for a Longer Life

A dumbbell resting on the floor, illustrating a Harvard study on the strength-training sweet spot for a longer life

A new Harvard study followed 147,374 adults for up to 30 years and pinpointed the strength-training sweet spot for living longer - and it is refreshingly modest. Just 90 to 120 minutes of resistance training per week was linked to a 13% lower risk of dying from any cause, a 19% lower risk of dying from cardiovascular disease, and a 27% lower risk of dying from neurological diseases like Alzheimer's. The benefits plateaued after about two hours a week - more lifting did not add more years. And pairing strength work with regular aerobic activity pushed the risk of early death down by up to 45%. Published in the British Journal of Sports Medicine, it is one of the largest and longest studies ever to measure exactly how much strength training it takes to move the needle on lifespan.

Read more →
Jun 15, 2026, 1:15 PM ETScience

Scientists Built a Battery-Free Device That Turns Sunlight, Water and CO2 Into Liquid Fuel - and It Regulates Itself

Rooftop solar photovoltaic panels under a clear sky, illustrating an artificial-photosynthesis system that uses sunlight to turn water and CO2 into liquid formic acid fuel

Researchers at Osaka Metropolitan University have built an artificial-photosynthesis reactor that converts sunlight, water and carbon dioxide into formic acid - a storable liquid fuel - and keeps production steady even as clouds come and go, without any battery or control electronics. The trick is a self-regulating solid electrolyte that acts as a chemical maximum-power-point tracker: as sunlight intensifies, the device gently warms, its electrical resistance falls, more current flows, and the solar cell stays parked near its peak-power sweet spot - all on its own. Published in EES Solar (Royal Society of Chemistry) and demonstrated at the Osaka Kansai Expo 2025, where it powered a working miniature diorama, the design removes one of the most expensive and failure-prone parts of solar-fuel systems. Inside: how artificial photosynthesis works, what maximum-power-point tracking is and why deleting the electronics matters, why formic acid is such a convenient solar fuel, and what comes next.

Read more →
Jun 15, 2026, 5:14 AM ETScience

Scientists Found One of the Most Light-Bending Crystals in Nature - and It Could Make AR Glasses and Smart Contact Lenses Vanishingly Thin

A calcite crystal demonstrating birefringence: text viewed through it appears doubled because the crystal splits light into two rays - the same light-bending phenomenon that the MoOCl2 crystal pushes to a record level.

Researchers have measured one of the strongest light-bending effects ever seen in a natural material: a layered crystal called molybdenum oxychloride (MoOCl2) with an in-plane birefringence of about 2.2 - more than ten times that of calcite, the mineral that held the record for over a century. The same crystal behaves like an optical chameleon, reflecting light like polished metal along one direction and turning transparent like glass when rotated 90 degrees, and it hits a rare epsilon-near-zero point at 512 nm in visible green light. Because the effect is so concentrated, optical parts made from it could be thousands of times thinner than a human hair - exactly what is needed for ultrathin AR glasses, on-eye displays and smart contact lenses. The work, published in the American Chemical Society journal Nano Letters, comes from Dubai-based smart-lens unicorn XPANCEO with collaborators at the National University of Singapore and the University of Chemistry and Technology, Prague. Full breakdown: what birefringence is, why 2.2 is a milestone, the one-dimensional atom chains behind it, and what it means for the glasses and lenses on the horizon.

Read more →
Jun 15, 2026, 12:37 AM ETTech

After Human-Level AI, What Comes Next? Inside Google DeepMind's New Roadmap From AGI to Superintelligence

Infographic of the evolutionary pathway from Narrow AI to AGI to Artificial Superintelligence (ASI), illustrating Google DeepMind's roadmap paper

Google DeepMind has published a 60-page paper, 'From AGI to ASI' (arXiv, June 10, 2026), asking what happens once machines reach human-level general intelligence - and how AI might keep going, toward artificial superintelligence. Co-authored by DeepMind co-founder Shane Legg and AIXI creator Marcus Hutter, it lays out a clear vocabulary (AGI, ASI, and the theoretical limit of 'Universal AI'), four concrete pathways beyond AGI (scaling, new algorithms, recursive self-improvement, and multi-agent collectives), six bottlenecks that could slow things down, and a striking central argument: the leap may not be one dramatic 'big bang' but a sustained series of breakthroughs across science and technology. It also grounds the hype by spelling out the hard physical and mathematical limits even a superintelligence cannot escape. Here is the full, accessible breakdown.

Read more →
Jun 15, 2026, 12:15 AM ETScience

MIT's One-Fuel Engine: A Single Green Propellant Powers Both Chemical and Electric Thrusters - and Could Send CubeSats to Mars

NASA/JPL-Caltech artist concept of the twin briefcase-sized MarCO CubeSats flying past Mars with Earth in the distance, illustrating how small satellites could reach the Red Planet - a journey made more feasible by MIT's one-fuel dual-mode green propulsion system

MIT engineers have demonstrated a two-in-one propulsion system in which a single, non-toxic green propellant powers both a chemical thruster (fast, powerful burns) and electric electrospray thrusters (slow, ultra-efficient cruising) from one shared fuel tank. The fuel is ASCENT - an ionic liquid about as thick as baby oil, originally synthesized by the U.S. Air Force as a safer alternative to highly toxic hydrazine. In lab tests, electrospray thrusters ran on just 1 gram of ASCENT each, continuously for up to 100 hours, with thrust comparable to the specialized fuels they normally use. Because tiny satellites usually can't fit two separate fuel systems, this 'best of both worlds' design could finally make briefcase-sized CubeSats nimble enough to journey to Mars or the asteroid belt. NASA will flight-test the concept on its Green Propulsion Dual Mode CubeSat, targeting a November 2026 launch. Published in the Journal of Propulsion and Power.

Read more →
Jun 14, 2026, 1:34 PM ETScience

China's JUNO Just Released Its First Neutrino Results - and in Only 59 Days They're Already the Most Precise Ever Made

Labeled cutaway diagram of the JUNO (Jiangmen Underground Neutrino Observatory) detector, showing the central acrylic sphere filled with liquid scintillator, the surrounding photomultiplier tubes, the water pool, and the top tracker.

The Jiangmen Underground Neutrino Observatory (JUNO) - a 20,000-tonne sphere of ultra-pure liquid sitting 700 meters under a mountain in southern China - published its first physics results in Nature on June 11, 2026. Using just 59 days of data, it measured two of the six numbers that govern how neutrinos oscillate (sin-squared theta_12 = 0.3092 +/- 0.0087 and delta-m-squared_21 = (7.50 +/- 0.12) x 10^-5 eV^2) with record accuracy - shrinking the uncertainty by a factor of about 1.6, roughly a 60% improvement over every previous experiment combined. Built by ~750 scientists from 74 institutions across 17 countries for more than $300 million, JUNO's headline goal is to crack the neutrino mass ordering, one of the deepest open puzzles in physics. These first results show it is on track to do exactly that within about six years.

Read more →
Jun 14, 2026, 5:14 AM ETHealth

A World First: Scientists Just Treated the First Person With a Therapy Designed to Make Aging Cells Young Again

A color fundus photograph of a healthy human retina and optic nerve head, illustrating the eye - the first target of Life Biosciences' ER-100 cellular reprogramming therapy

On June 9, 2026, Boston-based Life Biosciences dosed the first patient in its Phase 1 trial of ER-100 - described by Nature and Scientific American as the world's first clinical trial of partial cellular reprogramming in a human being. The one-time gene therapy is delivered to the eye and switches on three of the four classic Yamanaka factors - OCT4, SOX2 and KLF4 (OSK) - to gently reset a cell's epigenetic age toward a younger, healthier state without erasing its identity. The fourth factor, c-Myc, is deliberately left out to avoid cancer risk. The first targets are open-angle glaucoma and NAION, a sudden cause of vision loss in older adults that currently has no approved treatment. It builds on a decade of work, including David Sinclair's 2020 Nature study that reversed vision loss in aged mice. This is a Phase 1 safety trial - it is early days - but a concept once confined to petri dishes and mice has now, for the first time, reached a person.

Read more →
Jun 14, 2026, 12:13 AM ETHealth

Your Brain Can Keep Getting Stronger - Even Into Your 90s, a 3-Year Study of Nearly 4,000 Adults Finds

An anatomical drawing of the human brain from the U.S. National Institute on Aging, illustrating a 2026 study showing brain health can improve at any age

A three-year study of 3,966 adults aged 19 to 94, published in May 2026 in Nature Portfolio's journal Scientific Reports, found that brain health is not locked in by age - it can measurably improve at any stage of life, including in people in their 80s and 90s. Researchers at the Center for BrainHealth at UT Dallas tracked participants for more than 1,000 days using the BrainHealth Index, a composite of about 20 validated measures across three domains: Clarity (thinking), Connectedness (people and purpose), and Emotional Balance (resilience). The biggest surprise: the strongest predictor of improvement was not age, gender, or education - it was engagement. The people who started with the lowest scores improved the most, even top performers kept gaining past 1,000 days, and the largest gains were linked to just 5 to 15 minutes a day of strategy-based brain training plus brain-healthy habits. Full breakdown: how brain health was measured, what they found, the practical daily takeaways, and the honest limitations.

Read more →
Jun 13, 2026, 10:42 PM ETHealth

Stanford Scientists Regrow Lost Knee Cartilage by Blocking a Single 'Aging Enzyme' - No Stem Cells Needed

Anatomical photograph of a human knee joint, illustrating a Stanford study showing that blocking the aging enzyme 15-PGDH regrew joint cartilage

In a study published in Science on June 12, 2026, Stanford Medicine researchers showed that blocking one aging-related enzyme - 15-PGDH, which they call a 'gerozyme' - regrew lost joint cartilage in aged mice, prevented arthritis after injury, and prompted human cartilage tissue to start regenerating. The regrown tissue was hyaline cartilage, the real functional kind, and it happened by rejuvenating existing cartilage cells rather than using stem cells. Encouragingly, an oral 15-PGDH inhibitor is already in early human clinical trials (for age-related muscle weakness) and has passed Phase 1 safety. Osteoarthritis affects hundreds of millions of people and has no approved disease-modifying drug - so a treatment that targets the root cause would be a major shift. The honest caveats: the cartilage results are in mice and in lab tissue samples, not yet a full human trial.

Read more →
Jun 13, 2026, 9:33 AM ETTech

U.S. Government Orders Anthropic to Disable Claude Fable 5 and Mythos 5 - Three Days After Launch

The U.S. Capitol, representing the U.S. government export-control directive that forced Anthropic to disable its Claude Fable 5 and Mythos 5 AI models in June 2026

In what appears to be a first for the AI industry, the U.S. government on June 12, 2026 issued an export-control directive - citing national-security authority - forcing Anthropic to abruptly disable its two most powerful models, Claude Fable 5 and Mythos 5, worldwide. Fable 5 had launched only three days earlier, on June 9. The order targets foreign nationals, but because Anthropic cannot separate them from U.S. users in real time, it pulled both models for everyone. The government's concern is a claimed 'jailbreak'; Anthropic publicly disagrees, calling it a narrow, non-universal issue whose capability is 'widely available from other models (including OpenAI's GPT-5.5).' All other Claude models remain online. Here's exactly what happened, both sides of the argument, and why this is a landmark moment for AI policy.

Read more →
Jun 13, 2026, 2:23 AM ETTech

SpaceX Just Pulled Off the Largest IPO in History - and Made Elon Musk the World's First Trillionaire (On Paper)

A SpaceX Falcon Heavy rocket lifting off, illustrating SpaceX's record-breaking June 2026 Nasdaq IPO under ticker SPCX

SpaceX debuted on Nasdaq (ticker SPCX) on Friday, June 12, 2026, selling 555.6 million shares at $135 to raise roughly $75 billion - more than 2.5x the previous record (Saudi Aramco, 2019) - at a $1.77 trillion pricing valuation. The stock opened at $150, spiked as high as $176.52 (+31%), and closed up 19% at $160.95, pushing SpaceX's market cap to about $2.1 trillion and tipping Elon Musk's net worth past $1 trillion on paper. But the company is unprofitable (~$8.7B in losses) and priced near 100x sales - Morningstar pegs fair value 53% below the IPO price. Full breakdown: the exact numbers, what the money is for (including orbital AI data centers), the bull-vs-bear case, and the AI IPO wave (Anthropic, OpenAI) right behind it.

Read more →